SoloPace Announces US Commercial Release of the SOLO PACE FUSION Temporary Pacing System Following FDA 510(k) Clearance
PR Newswire —
New temporary pacing system is designed to improve patient safety, reduce costs, and enhance efficiency for transcatheter heart valve (THV) procedures. SAN FRANCISCO, March 31, 2026 /PRNewswire/ -- Solo Pace Incorporated, an emerging medical technology company, today announced the...